Fusion of the ECD component to the 3 mAbs generally resulted in an increased hydrophobicity, relative to parent mAb, as evidenced by increased retention time

Fusion of the ECD component to the 3 mAbs generally resulted in an increased hydrophobicity, relative to parent mAb, as evidenced by increased retention time. Evaluation of the cellular distribution of the constructs suggested that the major clearance mechanism was linked to binding/association with liver sinusoidal endothelial cells (LSECs) versus liver macrophages. The role of LSECs in facilitating the clearance of the IgG-ECD and IgG-scFv BsAb constructs described in these studies was consistent with the minimal influence of clodronate-mediated macrophage depletion around the pharmacokinetics of the constructs in cynomolgus monkeys The findings in this report are an important demonstration that this elucidation Lifirafenib of clearance mechanisms for some IgG-ECD and IgG-scFv BsAb molecules can be unique and complicated, Lifirafenib and may require increased attention due to the proliferation of these more complex mAb-like structures. KEYWORDS: Antibody pharmacokinetics, bifunctional antibodies, bispecific antibodies, clodronate, liver sinusoidal endothelial cells, non-specific binding Abbreviations BsAbsbispecific antibodiesmAbmonoclonal antibodyECDextracellular domainscFvsingle chain variable fragmentLSECsliver sinusoidal endothelial cellsTMDDtarget-mediated drug dispositionIVintravenousGly-SerGlycine-SerineVEGF-Avascular endothelial growth factorPlGFplacental growth factor (PlGF)SPRsurface plasmon resonanceHCheavy chainFcRnneonatal Fc receptorRUsresonance unitsKbased on their primary amino acid sequence using Vector NTI software were comparable to those decided through empirical isoelectric focusing methods (Table?1). For the majority of these molecules, we observed that this experimentally decided pI values fell within a narrow pH range from 7.5 to 8.5, indicating that, at physiological pH, these molecules would be expected to have a very weak to weak positive charge. Additionally, it was noted that fusion of the parental mAb did not grossly alter the molecules apparent charge properties (Table?1). Given that the glycocalyx of endothelial cells creates a negatively charged surface that Rabbit Polyclonal to OR2M3 can promote non-productive charge-based interactions, we leveraged a heparin-based surrogate column assay to determine the degree of charge-based interaction for each of the molecules evaluated in this study. In this experiment, samples were injected over a column of heparin sepharose, and then eluted with a linear gradient of increasing ionic strength. Retention of compound and elution time was then used to determine the potential for charge-based interactions. Despite the slight positive charge present on all of the molecules tested, we observed that the majority of the molecules were not retained by the column. For the few molecules that did show retention, all were noted to elute at sodium chloride concentrations that approximate those found under physiological conditions (Table?1). The relative comparison of the parental mAbs with their BsAb counterparts indicated no gross change in Lifirafenib column association, with the noted exception of GB and GB-sc2. nonspecific interactions driven by hydrophobic association were evaluated using a HIC-based column assay in which molecules were formulated in high ionic strength (1?M ammonium sulfate solution at pH 6.7), and then injected onto a solid phase hydrophobic resin. Retained materials were eluted from the column with a linear gradient of low ionic strength and hydrophobicity was assessed as a function of retention time. Fusion of the ECD component to the 3 mAbs generally resulted in an increased hydrophobicity, relative to parent mAb, as evidenced by increased retention time. However, evaluation of GB and GB-sc2 did not show any specific increase in hydrophobicity as both proteins were not retained under the conditions tested. Perturbations to the structural integrity (or thermal stability) of the mAbs and BsAbs were measured by differential scanning calorimetry (DSC; Table?1). Analysis of G1 and G1-ECD indicated that fusion of ECD to the C-terminal end of G1 lead to a slight decrease in the overall thermal stability of the CH2 domain present in G1 (3C), while no changes in CH3 or Fab domains were measured. In the context of G2 or G3, no gross changes in any domain of the IgG were found to be perturbed. Furthermore, the Tm of the ECD was found to be invariant regardless of the antibody to which it was fused. With respect to GB and GB-sc2, compared to each other, no gross alteration of the thermal stability of any Lifirafenib domains within in the molecules were found to be altered. The cynomolgus monkey FcRn.